Učitavanje...

A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrier

The observation that approximately 15% of women with disseminated breast cancer will develop symptomatic brain metastases combined with treatment guidelines discouraging single-agent chemotherapeutic strategies facilitates the desire for novel strategies aimed at outright brain metastasis prevention...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Prev Res (Phila)
Glavni autori: Adkins, Chris E, Nounou, Mohamed I, Mittapalli, Rajendar K, Terrell-Hall, Tori B, Mohammad, Afroz S, Jagannathan, Rajaganapathi, Lockman, Paul R
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311570/
https://ncbi.nlm.nih.gov/pubmed/25348853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-14-0225
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!